<DOC>
	<DOCNO>NCT01357369</DOCNO>
	<brief_summary>This study propose look pharmacokinetics two drug ( Cefazolin ondansetron ) give routinely pregnant woman plan deliver via cesarean section . The investigator evaluate metabolism drug pregnant woman , placental transfer time , subsequent metabolism transfer drug neonate .</brief_summary>
	<brief_title>Study Drug Concentration Ondansetron Cefazolin Mothers Neonates</brief_title>
	<detailed_description>There little data drug metabolism pregnancy , may differ non-pregnant woman . There even less data placental transfer drug neonate medication give prior delivery . This study propose look pharmacokinetics two drug ( Cefazolin ondansetron ) give routinely pregnant woman plan deliver via cesarean section . The investigator evaluate metabolism drug pregnant woman , placental transfer time , subsequent metabolism transfer drug neonate . The investigator hope learn 1 ) pk profile drug pregnancy , differs non-pregnant woman , 2 ) placental transfer drug , 3 ) profile neonatal metabolism drug cross placental barrier .</detailed_description>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Adult participant : Age 1845 year old Term pregnancy ( 3742 week ) Delivers plan cesarean section , unplanned , nonurgent cesarean section . Generally healthy Able willing sign inform consent Neonatal participant : Male female 3742 week gestation Adult : Medical condition would effect metabolism study drug Known allergy either study medication Use medication last 48 hour might induce inhibit metabolism ondansetron ( e.g . barbiturate , fluconazole , erythromycin , etc . )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>bacteria infection</keyword>
</DOC>